Department of Pediatrics Archive
-
October 17, 2013
Fellow tracks post-vaccination bacterial trends
Pediatric Infectious Diseases fellow Annabelle de St. Maurice, M.D., has been awarded a grant to determine the relationship between pneumococcal vaccination and the emergence of certain strains of pneumococcal bacteria not covered by vaccines. -
September 26, 2013
Vaccine Research Program lands major NIH renewal
The Vanderbilt Vaccine Research Program has received a major contract from the National Institutes of Health to continue its work as one of the nation’s Vaccine and Treatment Evaluation Units. -
September 19, 2013
VU testing vaccine against new flu threat
Vanderbilt’s Vaccine and Treatment Evaluation Unit (VTEU) is one of nine U.S. sites funded by the National Institute of Allergy and Infectious Disease (NIAID), part of the National Institutes of Health (NIH), to test the effectiveness of a vaccine to protect against the H7N9 bird flu that emerged in China this spring. -
September 19, 2013
Hyundai award helps drive hope for cancer research
Emmanuel Volanakis, M.D., assistant professor of Pediatrics and Hematology/Oncology, was awarded a $250,000 Hyundai Hope On Wheels grant last week for his ongoing research into T-cell acute lymphoblastic leukemia (ALL), an aggressive blood cancer. -
September 12, 2013
VU tracking drug’s ability to prevent type 1 diabetes
Vanderbilt’s Eskind Diabetes Clinic has been selected to examine the ability of the drug abatacept to prevent type 1 diabetes (T1D). As part of the TrialNet consortium, Vanderbilt will be one of 14 North American sites observing the effects of the drug in people at high risk to develop T1D. -
September 12, 2013
Options to treat childhood C. diff. infection studied
After more than a month in and out of the hospital with her daughter, Kynslee, Kristen Allen felt she was at the end of her rope. Last spring, the nearly 2-year-old Columbia girl developed diarrhea that wouldn’t go away after taking antibiotics for repeated ear infections. -
September 12, 2013
‘Proofreader’ key to coronavirus growth
A coronavirus protein is required for replication of the viral genome and may be a good treatment target for SARS and other diseases caused by coronaviruses.